Propaten Randomized Investigation on Cost-benefit and Efficacy
Stopped Results from futility analysis conducted at planned interim time-point did not meet the study criteria for continuation.
Conditions
Interventions
- DEVICE: PROPATEN
- DEVICE: Standard Graft
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
- [object Object]
- [object Object]
- [object Object]